Sterling Investment Advisors Ltd. Buys Shares of 2,025 Astera Labs, Inc. $ALAB

Sterling Investment Advisors Ltd. bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 2,025 shares of the company’s stock, valued at approximately $337,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Nordea Investment Management AB purchased a new position in shares of Astera Labs in the fourth quarter valued at $2,028,000. Geneva Partners LLC purchased a new position in shares of Astera Labs in the third quarter valued at $1,876,000. Numerai GP LLC increased its position in shares of Astera Labs by 153.1% in the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after buying an additional 7,992 shares in the last quarter. Handelsbanken Fonder AB increased its position in shares of Astera Labs by 289.5% in the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after buying an additional 93,800 shares in the last quarter. Finally, Paragon Advisors LLC purchased a new position in shares of Astera Labs in the third quarter valued at $1,829,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the company. JPMorgan Chase & Co. raised their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. TD Cowen raised their price target on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research report on Wednesday, May 6th. Royal Bank Of Canada raised their price target on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. Jefferies Financial Group restated a “buy” rating and issued a $270.00 price target on shares of Astera Labs in a research report on Wednesday, May 6th. Finally, Needham & Company LLC raised their price target on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Price Performance

NASDAQ ALAB opened at $306.88 on Tuesday. The firm has a market capitalization of $52.60 billion, a P/E ratio of 207.35, a P/E/G ratio of 4.06 and a beta of 3.35. Astera Labs, Inc. has a 1-year low of $84.78 and a 1-year high of $315.81. The business’s 50-day simple moving average is $174.13 and its 200-day simple moving average is $160.46.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company’s revenue was up 93.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Insider Activity

In other news, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $249.19, for a total value of $69,773,200.00. Following the transaction, the chief operating officer directly owned 615,000 shares of the company’s stock, valued at $153,251,850. The trade was a 31.28% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of Astera Labs stock in a transaction dated Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer directly owned 4,079,322 shares in the company, valued at $702,214,489.08. This represents a 7.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,915,461 shares of company stock valued at $358,508,976 in the last three months. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.